AQR Capital Management - KARUNA THERAPEUTICS INC ownership

KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 162 filers reported holding KARUNA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 3.11 and the average weighting 0.4%.

Quarter-by-quarter ownership
AQR Capital Management ownership history of KARUNA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$690,563
-39.4%
4,084
-22.3%
0.00%
-50.0%
Q2 2023$1,139,113
+7.2%
5,253
-10.2%
0.00%0.0%
Q1 2023$1,062,231
-58.3%
5,848
-54.9%
0.00%
-66.7%
Q4 2022$2,547,819
-2.8%
12,966
+11.2%
0.01%0.0%
Q3 2022$2,622,000
+724.5%
11,658
+363.9%
0.01%
+500.0%
Q2 2022$318,000
+9.7%
2,513
-12.0%
0.00%0.0%
Q4 2020$290,0002,8570.00%
Other shareholders
KARUNA THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Pivotal bioVenture Partners Investment Advisor LLC 782,008$142,043,93358.49%
Nan Fung Group Holdings Ltd 225,688$40,993,96827.90%
Sofinnova Investments, Inc. 1,773,124$322,070,24320.60%
Artia Global Partners LP 88,831$16,135,2635.96%
DAFNA Capital Management LLC 78,573$14,272,0004.28%
First Light Asset Management, LLC 243,675$44,261,1273.98%
CATALYST PRIVATE WEALTH, LLC 21,837$3,966,4732.74%
Sands Capital Ventures, LLC 58,895$10,697,6882.64%
ARCH Venture Management, LLC 30,000$5,449,2002.63%
Logos Global Management LP 100,000$18,164,0002.60%
View complete list of KARUNA THERAPEUTICS INC shareholders